Collegium to Participate in Upcoming Investor Conferences
Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences:
马萨诸塞州斯托顿,2024年11月12日(环球新闻社) - Collegium Pharmaceutical, Inc.(纳斯达克:COLL),一家领先的多元化特殊药品公司,致力于改善与严重医疗条件患者的生活,今天宣布管理层将参加以下投资者会议:
Jefferies London Healthcare Conference
Fireside Chat Date and Time: Tuesday, November 19, 2024, at 1:30 p.m. GMT
杰富瑞伦敦医疗保健大会
炉边聊天日期和时间:2024年11月19日星期二,格林威治标准时间下午1点30分
Piper Sandler 36th Annual Healthcare Conference
Fireside Chat Date and Time: Thursday, December 5, 2024, at 1:00 p.m. ET
派杰投资第36届医疗保健年会
炉边聊天日期和时间:2024年12月5日星期四,美国东部时间下午1点
The fireside chats will be webcast live and can be accessed from the Investors section of the Company's website: . A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
炉边谈话将通过公司网站的投资者部分进行网络直播,并可从该公司的网站上进行访问: 。网络直播的重播将在演示结束后的90天内存档在公司的网站上。
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company's website at .
关于 Collegium Pharmaceutical, Inc.
Collegium是一家领先的多元化特殊药品公司,致力于改善患有严重医疗状况的人们的生活。 Collegium的总部位于马萨诸塞州斯托顿。 欲了解更多信息,请访问公司网站: 。
Investor Contact:
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
投资者联系人:
Danielle Jesse
投资者关系董事
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com
媒体联系:
Marissa Samuels
企业通信副总裁
communications@collegiumpharma.com